Drug syringe safely label

- QuVa Pharma, Inc.
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

The patent or application file contains at least one drawing executed in color. Copies of this patent with color drawings will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a top plan view of the first embodiment of a drug syringe safety label, showing our new design;

FIG. 2 is a perspective view of the first embodiment of a drug syringe safety label shown in an environment of use;

FIG. 3 is a left side elevation view thereof;

FIG. 4 is a right side elevation view thereof;

FIG. 5 is a top plan view thereof;

FIG. 6 is a bottom plan view thereof;

FIG. 7 is a front elevation view thereof;

FIG. 8 is a back elevation view thereof;

FIG. 9 is a top plan view of the second embodiment of a drug syringe safety label, showing our new design;

FIG. 10 is a perspective view of the second embodiment of a drug syringe safety label shown in an environment of use;

FIG. 11 is a left side elevation view thereof;

FIG. 12 is a right side elevation view thereof;

FIG. 13 is a top plan view thereof;

FIG. 14 is a bottom plan view thereof;

FIG. 15 is a front elevation view thereof;

FIG. 16 is a back elevation view thereof;

FIG. 17 is a top plan view of the third embodiment of a drug syringe safety label, showing our new design;

FIG. 18 is a perspective view of the third embodiment of a drug syringe safety label shown in an environment of use;

FIG. 19 is a left side elevation view thereof;

FIG. 20 is a right side elevation view thereof;

FIG. 21 is a top plan view thereof;

FIG. 22 is a bottom plan view thereof;

FIG. 23 is a front elevation view thereof;

FIG. 24 is a back elevation view thereof;

FIG. 25 is a top plan view of the fourth embodiment of a drug syringe safety label, showing our new design;

FIG. 26 is a perspective view of the fourth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 27 is a left side elevation view thereof;

FIG. 28 is a right side elevation view thereof;

FIG. 29 is a top plan view thereof;

FIG. 30 is a bottom plan view thereof;

FIG. 31 is a front elevation view thereof;

FIG. 32 is a back elevation view thereof;

FIG. 33 is a top plan view of the fifth embodiment of a drug syringe safety label, showing our new design;

FIG. 34 is a perspective view of the fifth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 35 is a left side elevation view thereof;

FIG. 36 is a right side elevation view thereof;

FIG. 37 is a top plan view thereof;

FIG. 38 is a bottom plan view thereof;

FIG. 39 is a front elevation view thereof;

FIG. 40 is a back elevation view thereof;

FIG. 41 is a top plan view of the sixth embodiment of a drug syringe safety label, showing our new design;

FIG. 42 is a perspective view of the sixth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 43 is a left side elevation view thereof;

FIG. 44 is a right side elevation view thereof;

FIG. 45 is a top plan view thereof;

FIG. 46 is a bottom plan view thereof;

FIG. 47 is a front elevation view thereof;

FIG. 48 is a back elevation view thereof;

FIG. 49 is a top plan view of the seventh embodiment of a drug syringe safety label, showing our new design;

FIG. 50 is a perspective view of the seventh embodiment of a drug syringe safety label shown in an environment of use;

FIG. 51 is a left side elevation view thereof;

FIG. 52 is a right side elevation view thereof;

FIG. 53 is a top plan view thereof;

FIG. 54 is a bottom plan view thereof;

FIG. 55 is a front elevation view thereof;

FIG. 56 is a back elevation view thereof;

FIG. 57 is a top plan view of the eighth embodiment of a drug syringe safety label, showing our new design;

FIG. 58 is a perspective view of the eighth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 59 is a left side elevation view thereof;

FIG. 60 is a right side elevation view thereof;

FIG. 61 is a top plan view thereof;

FIG. 62 is a bottom plan view thereof;

FIG. 63 is a front elevation view thereof;

FIG. 64 is a back elevation view thereof;

FIG. 65 is a top plan view of the ninth embodiment of a drug syringe safety label, showing our new design;

FIG. 66 is a perspective view of the ninth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 67 is a left side elevation view thereof;

FIG. 68 is a right side elevation view thereof;

FIG. 69 is a top plan view thereof;

FIG. 70 is a bottom plan view thereof;

FIG. 71 is a front elevation view thereof;

FIG. 72 is a back elevation view thereof;

FIG. 73 is a top plan view of the tenth embodiment of a drug syringe safety label, showing our new design;

FIG. 74 is a perspective view of the tenth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 75 is a left side elevation view thereof;

FIG. 76 is a right side elevation view thereof;

FIG. 77 is a top plan view thereof;

FIG. 78 is a bottom plan view thereof;

FIG. 79 is a front elevation view thereof;

FIG. 80 is a back elevation view thereof;

FIG. 81 is a top plan view of the eleventh embodiment of a drug syringe safety label, showing our new design;

FIG. 82 is a perspective view of the eleventh embodiment of a drug syringe safety label shown in an environment of use;

FIG. 83 is a left side elevation view thereof;

FIG. 84 is a right side elevation view thereof;

FIG. 85 is a top plan view thereof;

FIG. 86 is a bottom plan view thereof;

FIG. 87 is a front elevation view thereof;

FIG. 88 is a back elevation view thereof;

FIG. 89 is a top plan view of the twelfth embodiment of a drug syringe safety label, showing our new design;

FIG. 90 is a perspective view of the twelfth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 91 is a left side elevation view thereof;

FIG. 92 is a right side elevation view thereof;

FIG. 93 is a top plan view thereof;

FIG. 94 is a bottom plan view thereof;

FIG. 95 is a front elevation view thereof;

FIG. 96 is a back elevation view thereof;

FIG. 97 is top plan view of the thirteenth embodiment of a drug syringe safety label, showing our new design;

FIG. 98 is a perspective view of the thirteenth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 99 is a left side elevation view thereof;

FIG. 100 is a right side elevation view thereof;

FIG. 101 is a top plan view thereof;

FIG. 102 is a bottom plan view thereof;

FIG. 103 is a front elevation view thereof;

FIG. 104 is a back elevation view thereof;

FIG. 105 is a top plan view of the fourteenth embodiment of a drug syringe safety label, showing our new design;

FIG. 106 is a perspective view of the fourteenth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 107 is a left side elevation view thereof;

FIG. 108 is a right side elevation view thereof;

FIG. 109 is a top plan view thereof;

FIG. 110 is a bottom plan view thereof;

FIG. 111 is a front elevation view thereof;

FIG. 112 is a back elevation view thereof;

FIG. 113 is top plan view of the fifteenth embodiment of a drug syringe safety label, showing our new design;

FIG. 114 is a perspective view of the fifteenth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 115 is a left side elevation view thereof;

FIG. 116 is a right side elevation view thereof;

FIG. 117 is a top plan view thereof;

FIG. 118 is a bottom plan view thereof;

FIG. 119 is a front elevation view thereof;

FIG. 120 is a back elevation view thereof;

FIG. 121 is a top plan view of the sixteenth embodiment of a drug syringe safety label, showing our new design;

FIG. 122 is a perspective view of the sixteenth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 123 is a left side elevation view thereof;

FIG. 124 is a right side elevation view thereof;

FIG. 125 is a top plan view thereof;

FIG. 126 is a bottom plan view thereof;

FIG. 127 is a front elevation view thereof;

FIG. 128 is a back elevation view thereof;

FIG. 129 is an unfolded top plan view of the seventeenth embodiment of a drug syringe safety label, showing our new design;

FIG. 130 is a perspective view of the seventeenth embodiment of a drug syringe safety label shown in an environment of use;

FIG. 131 is a left side elevation view thereof;

FIG. 132 is a right side elevation view thereof;

FIG. 133 is a top plan view thereof;

FIG. 134 is a bottom plan view thereof;

FIG. 135 is a front elevation view thereof; and,

FIG. 136 is a back elevation view thereof.

The broken line portion of the drug syringe safety label is included to show portions of the article that form no part of the claimed design. The syringe shown in broken lines illustrates environment that forms no part of the claimed design.

Claims

We claim the ornamental design for a drug syringe safety label, as shown and described.

Referenced Cited
U.S. Patent Documents
3368741 February 1968 Mercur
3537637 November 1970 Hiersteiner
4621729 November 11, 1986 Jackson
4884827 December 5, 1989 Kelley
D311423 October 16, 1990 DeSantis
D360578 July 25, 1995 Dees
5651775 July 29, 1997 Walker et al.
6068300 May 30, 2000 Vijuk
D435662 December 26, 2000 Stevens
D435663 December 26, 2000 Stevens
D435664 December 26, 2000 Stevens
6158778 December 12, 2000 Vijuk
D436182 January 9, 2001 Stevens et al.
D436183 January 9, 2001 Stevens
D444885 July 10, 2001 Conway
D444886 July 10, 2001 Conway
6685678 February 3, 2004 Evans et al.
6966897 November 22, 2005 Shimazaki
7469518 December 30, 2008 Baldwin
D588200 March 10, 2009 Langan et al.
D589566 March 31, 2009 Lee
D593613 June 2, 2009 Langan et al.
D595361 June 30, 2009 Langan et al.
D597608 August 4, 2009 Langan et al.
D602534 October 20, 2009 Langan et al.
D603455 November 3, 2009 Griena
D605228 December 1, 2009 Langan et al.
D605229 December 1, 2009 Langan et al.
D605230 December 1, 2009 Langan et al.
D607941 January 12, 2010 Langan et al.
D614703 April 27, 2010 Langan et al.
D621879 August 17, 2010 Langan et al.
D621880 August 17, 2010 Langan et al.
D624595 September 28, 2010 Langan et al.
D624596 September 28, 2010 Langan et al.
7815123 October 19, 2010 Conner et al.
D628649 December 7, 2010 Dean, Jr.
D633151 February 22, 2011 Langan et al.
D634367 March 15, 2011 Langan et al.
D634368 March 15, 2011 Langan
D634369 March 15, 2011 Langan et al.
7918830 April 5, 2011 Langan et al.
D639861 June 14, 2011 Langan
D639862 June 14, 2011 Langan
D639863 June 14, 2011 Langan
D641421 July 12, 2011 Langan et al.
D641422 July 12, 2011 Langan et al.
D643468 August 16, 2011 Langan et al.
D643469 August 16, 2011 Langan et al.
D643470 August 16, 2011 Langan et al.
D643471 August 16, 2011 Langan et al.
D643472 August 16, 2011 Langan et al.
D645094 September 13, 2011 Langan et al.
D649196 November 22, 2011 Langan et al.
D661742 June 12, 2012 Clark
8281929 October 9, 2012 Franks et al.
8356434 January 22, 2013 Alipour
8382717 February 26, 2013 Langan et al.
D677732 March 12, 2013 Clark
D679333 April 2, 2013 Jabara
8858506 October 14, 2014 Langan et al.
9867947 January 16, 2018 Appelbaum
D814630 April 3, 2018 Finke et al.
10095997 October 9, 2018 Adler et al.
D861796 October 1, 2019 Hahn
D877255 March 3, 2020 Iglesias
D905788 December 22, 2020 Kumar
20080188814 August 7, 2008 Lavi-Loebl et al.
20150025472 January 22, 2015 Colwell
20160321962 November 3, 2016 Koltchine et al.
Foreign Patent Documents
2008229926 October 2008 JP
2013169419 September 2013 JP
2014200301 October 2014 JP
Other references
  • American Society of Anesthesiologists; Statement on Creating Labels of Pharmaceuticals for use in Anesthesiology, Oct. 28, 2015; 4 pgs.
  • ASTM International; Designation: D4775/D4775M-09; Standard Specification for Identification and Configuration of Prefilled Syringes and Delivery Systems for Drugs (Excluding Pharmacy Bulk Packages); 2014; 2 pgs.
  • Medi-Dose EPS Flag and Receipt Labels—Thermal LDF100-T, https://www.medidose.com/flagandreceiptlabels-largethermal-ldf100-t.aspx; Mar. 20, 2019; 5 pgs.
  • Guidance for Industry; Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors, Draft Guidance, Apr. 19, 2013; 26 pgs.
  • DevineMedical; Health Care Logistics 6026 Flag Label Label, https://www.devinemedical.com/6026-Flag_Label_Laser-h/hcl-6026.html; Mar. 19, 2019; 5 pgs.
  • Differences in strength expression on product labels of compounders and conventional manufacturers may lead to Tosing errors (Sep. 24, 2018); 7 pages.
  • FDA Guidance Needed to Assure Safe Labeling Practices by 503A and 503B Compounders (Mar. 22, 2018); 7 pages.
  • Safetywires, Phenylephrine overdose, Nurse AdviseERR, Jan. 2019, vol. 17, issue 1, pp. 3-5.
  • USP <7> Labeling, Revision Bulletin (Apr. 26, 2019); 9 pages.
Patent History
Patent number: D942544
Type: Grant
Filed: May 31, 2019
Date of Patent: Feb 1, 2022
Assignee: QuVa Pharma, Inc. (Sugar Land, TX)
Inventors: Ngoc Banh (Cypress, TX), David Christopher Short (Sugar Land, TX)
Primary Examiner: Mary Ann Calabrese
Assistant Examiner: Catherine Ho
Application Number: 29/693,164
Classifications
Current U.S. Class: Substantially Rectangular Or Square (D20/27)